Ignite Creation Date:
2024-05-06 @ 5:58 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05498064
Status:
RECRUITING
Last Update Posted:
2022-08-11
First Post:
2022-05-17
Brief Title:
A Real World Study of Ensartinib in Advanced ALK-positive NSCLC
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-17
First Submit QC Date:
August 10 2022
Study First Post Date:
2022-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-10
Last Update Post Date:
2022-08-11
Last Update Post Date Type:
ACTUAL